loading

Finanzdaten der The Cooper Companies, Inc.-Aktie (COO)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-02-01 2024-10-31 2025-04-30 2025-01-31 2024-10-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
8.19%
713.57
777.19 1,002.30 964.70 1,018.40
Cost Of Revenue
2.79%
430.99
443.38 323.20 304.50 340.70
Gross Profit
15.35%
282.58
333.81 679.10 660.20 677.70
Operating Expenses
5.11%
311.98
296.83 494.30 478.20 479.30
Benefits Costs and Expenses
-
- 857.80 811.40 849.80
Costs And Expenses
1.98%
739.43
754.38 857.80 811.40 849.80
Operating Income/Loss
213.32%
-25.85
22.82 184.80 182.00 198.40
Income/Loss From Continuing Operations Before Tax
8.19%
713.57
777.19 144.50 153.30 168.60
Income/Loss From Continuing Operations After Tax
393.33%
-38.17
13.01 87.70 104.30 117.50
Net Income/Loss
393.33%
-38.17
13.01 87.70 104.30 117.50
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Earnings Per Share
420.00%
-800.00
250.00 0.44 0.52 0.59
Diluted Earnings Per Share
433.33%
-800.00
240.00 0.44 0.52 0.59
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
medical_instruments_supplies BAX
$24.16
price down icon 2.20%
$71.58
price down icon 2.09%
$67.25
price up icon 0.07%
$139.29
price down icon 2.22%
medical_instruments_supplies WST
$243.51
price down icon 1.45%
Kapitalisierung:     |  Volumen (24h):